BioMarin Pharmaceutical Inc.
US ˙ NasdaqGS ˙ US09061G1013

SecurityBMRN / BioMarin Pharmaceutical Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership8,435 shares
Latest Disclosed Value $ 455,659
Wolverine Trading, Llc ownership in BMRN / BioMarin Pharmaceutical Inc.

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 8,435 shares of BioMarin Pharmaceutical Inc. (US:BMRN) valued at $456,840 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 18, 2025 disclosing 5,089 shares of BioMarin Pharmaceutical Inc.. This represents a change in shares of 65.75% during the quarter. The current value of the position is $461,057 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (BMRN) in the form of stock options. The firm currently holds call options representing 80,900 of underlying shares valued at $4,370,218 USD and put options representing 27,100 of underlying shares valued at $1,463,942 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

BMRN / BioMarin Pharmaceutical Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 8,435 3,346 65.75 456 62.50 0.0003
2025-08-18 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,089 5,089 281 0.0003
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -20,927 -100.00 0 -100.00
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 20,927 20,927 1,477 0.0016
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -10,225 -100.00 0 -100.00
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 10,225 10,225 893 0.0009
2023-11-15 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -14,656 -100.00 0 -100.00
2023-08-23 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 14,656 14,656 1,303 0.0016
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -9,237 -100.00 0 -100.00
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,237 -5,601 -37.75 786 -36.87 0.0013
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 14,838 781 5.56 1,245 13.70 0.0021
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 14,057 -5,709 -28.88 1,095 -37.82 0.0014
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 19,766 4,665 30.89 1,761 51.81 0.0021
2021-11-12 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,101 -717 -4.53 1,160 -12.12 0.0013
2021-08-06 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 15,818 -957 -5.70 1,320 5.01 0.0021
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 16,775 4,590 37.67 1,257 18.58 0.0019
2021-02-12 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 12,185 -6,332 -34.20 1,060 -24.66 0.0017
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 18,517 13,696 284.09 1,407 138.88 0.0034
2020-08-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,821 -253 -4.99 589 40.57 0.0016
2020-05-11 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,074 -389 -7.12 419 -9.31 0.0013
2020-02-12 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 5,463 1,296 31.10 462 62.11 0.0011
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 4,167 4,167 285 0.0008
2019-02-13 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 0 -9,954 -100.00 0 -100.00
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 9,954 2,096 26.67 965 51.49 0.0021
2018-08-13 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,858 0 0.00 637 0.00 0.0015
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM 09061G101 7,858 4,419 128.50 637 99.69 0.0015
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,439 36 1.06 319 19.48 0.0015
2016-08-17 2016-06-30 13F/A-1 BIOMARIN PHARMACEUTICAL COM 09061G101 3,403 3,403 267 0.0015
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM 09061G101 3,403 267
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 80,900 18.97 4,370 16.50 n/a n/a n/a
2025-08-18 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 68,000 102.99 3,752 56.75 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 33,500 -21.73 2,393 -14.57 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 42,800 28.92 2,801 19.55 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 33,200 2,343 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 16,000 1,397 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-15 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 32,500 35.42 2,876 34.72 n/a n/a n/a
2023-08-23 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 24,000 -33.88 2,134 71,033.33 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 36,300 69.63 3 -99.86 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 21,400 100.00 2,215 143.41 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 10,700 4.90 910 6.31 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 10,200 7.37 856 15.68 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 9,500 -47.22 740 -53.84 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 18,000 -32.08 1,603 -21.23 n/a n/a n/a
2021-11-12 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 26,500 -5.69 2,035 -13.22 n/a n/a n/a
2021-08-06 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 28,100 -23.43 2,345 -14.76 n/a n/a n/a
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 36,700 -39.14 2,751 -47.54 n/a n/a n/a
2021-02-12 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 60,300 -14.59 5,244 -2.27 n/a n/a n/a
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 70,600 48.63 5,366 -7.55 n/a n/a n/a
2020-08-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 47,500 25.33 5,804 85.67 n/a n/a n/a
2020-05-11 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 37,900 -31.46 3,126 -33.18 n/a n/a n/a
2020-02-12 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 55,300 0.91 4,678 24.98 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 54,800 3,743 n/a n/a n/a
2019-08-20 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 35,100 -11.36 3,118 -5.83 n/a n/a n/a
2019-02-13 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 39,600 57.77 3,311 36.03 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 25,100 41.81 2,434 69.62 n/a n/a n/a
2018-08-13 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 17,700 0.00 1,435 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Call 17,700 -17.67 1,435 -25.14 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM Call 21,500 82.20 1,917 74.59 n/a n/a n/a
2017-11-15 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 11,800 6.31 1,098 6.60 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM Call 11,100 -19.57 1,030 -4.81 n/a n/a n/a
2016-08-17 2016-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Call 13,800 1,082 n/a n/a n/a
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM Call 138 1,082 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 27,100 26.05 1,464 23.36 n/a n/a n/a
2025-08-18 2025-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 21,500 -8.90 1,186 -29.61 n/a n/a n/a
2025-05-15 2025-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 23,600 9.26 1,686 19.25 n/a n/a n/a
2025-02-14 2024-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 21,600 -11.48 1,414 -17.94 n/a n/a n/a
2024-11-14 2024-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 24,400 1,722 n/a n/a n/a
2024-08-14 2024-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 13,000 1,135 n/a n/a n/a
2024-02-14 2023-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-11-15 2023-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 7,700 -64.84 681 -65.02 n/a n/a n/a
2023-08-23 2023-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 21,900 112.62 1,948 n/a n/a n/a
2023-05-15 2023-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 10,300 -45.50 1 -100.00 n/a n/a n/a
2023-02-14 2022-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 18,900 52.42 1,956 85.40 n/a n/a n/a
2022-11-14 2022-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 12,400 -22.50 1,055 -21.44 n/a n/a n/a
2022-08-15 2022-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 16,000 40.35 1,343 51.24 n/a n/a n/a
2022-05-16 2022-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 11,400 -35.96 888 -44.01 n/a n/a n/a
2022-02-14 2021-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 17,800 -48.85 1,586 -40.64 n/a n/a n/a
2021-11-12 2021-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 34,800 -10.31 2,672 -17.48 n/a n/a n/a
2021-08-06 2021-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 38,800 18.65 3,238 32.11 n/a n/a n/a
2021-05-14 2021-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 32,700 -30.28 2,451 -39.90 n/a n/a n/a
2021-02-12 2020-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 46,900 23.75 4,078 41.60 n/a n/a n/a
2020-11-13 2020-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 37,900 7.37 2,880 -33.23 n/a n/a n/a
2020-08-13 2020-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 35,300 21.72 4,313 80.31 n/a n/a n/a
2020-05-11 2020-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 29,000 17.89 2,392 14.94 n/a n/a n/a
2020-02-12 2019-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 24,600 11.31 2,081 37.81 n/a n/a n/a
2019-11-14 2019-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 22,100 1,510 n/a n/a n/a
2019-08-20 2019-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-05-15 2019-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 36,300 57.83 3,225 67.71 n/a n/a n/a
2019-02-13 2018-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 23,000 -33.33 1,923 -42.51 n/a n/a n/a
2018-11-14 2018-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 34,500 58.26 3,345 89.30 n/a n/a n/a
2018-08-13 2018-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 21,800 0.00 1,767 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F BIOMARIN PHARMACEUTICAL COM Put 21,800 39.74 1,767 27.03 n/a n/a n/a
2018-02-14 2017-12-31 13F BIOMARIN PHARMACEUTICAL COM Put 15,600 321.62 1,391 304.36 n/a n/a n/a
2017-11-15 2017-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 3,700 -74.83 344 -74.78 n/a n/a n/a
2016-11-14 2016-09-30 13F BIOMARIN PHARMACEUTICAL COM Put 14,700 -14.53 1,364 1.19 n/a n/a n/a
2016-08-17 2016-06-30 13F/A BIOMARIN PHARMACEUTICAL COM Put 17,200 1,348 n/a n/a n/a
2016-08-15 2016-06-30 13F BIOMARIN PHARMACEUTICAL COM Put 172 1,348 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.